Assembly Biosciences Inc. (ASMB)
NASDAQ · Healthcare
Assembly Biosciences Inc. Operating Income 2016–2025
Assembly Biosciences Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Assembly Biosciences Inc. operating income for the quarter ending March 31, 2026 was -11.4 M, a 14.37% increase year-over-year.
- Assembly Biosciences Inc. operating income for the twelve months ending March 31, 2026 was -43.3 M, a 11.54% decrease year-over-year.
- Assembly Biosciences Inc. annual operating income for 2025 was -12.1 M, a 73.32% decrease from 2024.
- Assembly Biosciences Inc. annual operating income for 2024 was -45.4 M, a 29.74% decrease from 2023.
- Assembly Biosciences Inc. annual operating income for 2023 was -64.6 M, a 31.31% decrease from 2022.
- Assembly Biosciences Inc. annual operating income for 2022 was -94.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Assembly Biosciences Inc. Operating Income — FAQ
Assembly Biosciences Inc. (ASMB) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Assembly Biosciences Inc.'s operating income?
Assembly Biosciences Inc. (ASMB) reported operating income of -$12M for fiscal 2025.
Where can I see ASMB's operating income history?
The chart and table above show Assembly Biosciences Inc.'s operating income by year and by quarter, including the growth rate.